Institutional Ownership
Blueprint Medicines Corp
CUSIP 09627Y109COM2655787DQ1 2026
13D / 13G Filings
40
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
2
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
40 filings · latest Aug 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Aug 14, 2025 | Pentwater Capital Management LP | 13G | 6.0% | 3.90M | SEC |
| 2 | Aug 14, 2025 | Avoro Capital Advisors LLC | 13G/A | 0.6% | 375.0K | SEC |
| 3 | Aug 14, 2025 | T. Rowe Price Associates, Inc. | 13G/A | 2.3% | 1.47M | SEC |
| 4 | Jul 21, 2025 | M.H. Davidson &Amp; Co. | 13G | — | — | SEC |
| 5 | May 15, 2025 | Avoro Capital Advisors LLC | 13G | 6.0% | — | SEC |
| 6 | May 12, 2025 | Wellington Management Group LLP | 13G/A | 4.8% | 3.07M | SEC |
| 7 | Apr 23, 2025 | Blackrock, Inc. | 13G/A | 8.0% | 5.09M | SEC |
| 8 | Feb 12, 2025 | Fmr LLC | 13G/A | 3.5% | 2.25M | SEC |
| 9 | Nov 14, 2024 | Price T Rowe Associates Inc /Md/ | 13G/A | 8.5% | 5.39M | SEC |
| 10 | Apr 10, 2024 | Price T Rowe Associates Inc /Md/ | 13G/A | 10.2% | 6.25M | SEC |
30 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Blueprint Medicines Corp.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Kelleher Financial Advisors | 300 | $38.5K |
| 2 | Huntington National Bank | 1 | $129 |